Arkeon Biotechnologies

aTension.life is a company dedicated to improving the diagnosis and treatment of hypertension using precision medicine. By utilizing advanced mass spectrometry technology, they can pinpoint the root causes of uncontrolled hypertension with just one blood sample. Their goal is to offer personalized diagnostic options for better patient care and assist laboratories with dependable tools. Ultimately, aTension.life strives to enhance the lives of hypertensive patients by making innovative diagnostics readily available and enabling tailored therapies for more effective treatment.

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of people are left without adequate treatment options - and AI trained with complex disease data can solve this.

Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest breakthroughs in neurotechnology at-home. We leverage cutting edge research to develop drastically better solutions for the greatest challenges to brain health. AI powered, personalized Neurotech Our vision is that Brightmind.AI’s personalized brain stimulation solutions are available in homes worldwide, offering to address globally important challenges to brain health such as pain relief, preventing cognitive decline and treating depression. Our first Use Case – Migraine Current solutions fail to achieve satisfactory outcomes: about 25% of 80 million migraineurs in the US and Europe are dissatisfied with existing treatment options. Research indicates that the stimulation protocol we use reduces migraine attacks by over 50%, for up to 90% of migraineurs.

Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious diseases and cancer using novel proprietary arenavirus vector platforms. Hookipa´s TheraT® and Vaxwave® platforms have shown promising abilities to elicit high neutralizing antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches. Hookipa’s vectors are not impeded by vector-neutralizing antibodies and can be administered repeatedly, providing even greater immune protection. Levels of specific T cells generated by TheraT® are unprecedented in the field and have the potential to transform active immune-therapy in cancers. Hookipa has completed the active phase of a Phase 1 trial of a Vaxwave®-based vaccine against cytomegalovirus (CMV) and is finalizing clinical development plans for TheraT® in Human Papilloma Virus (HPV)- related head and neck cancers.

The patented technology developed by Lignovations allows for the creation of lignin particles in the colloidal state, which greatly enhances their effectiveness. Our technology can be used with various types of lignin sources, and it produces a sustainable biomaterial that can substitute harmful chemicals in everyday consumer goods.

VALANX Biotech creates a unique method of attaching proteins to specific sites for use in treatments, diagnoses, and biocatalysis.

Sarcura creates a machine platform for the mass production of customized cell therapies in industry. Our goal is to increase the number of doses produced globally for these life-saving, patient-specific cancer treatments from thousands to hundreds of thousands each year while keeping costs low and patient safety high. By bringing bioprocess control down to the cellular level using semiconductor technology, we will revolutionize current production paradigms. AUTOMATE MINIATURIZE INTEGRATE

Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade undruggable targets. The platform Celeris One exploits the potential of degrader technologies with accurate predictions of biomolecular interactions and the expansion of chemical space. Celeris One uses methods such as Graph Representation Learning, Active Learning, Data Augmentation, and Generative Models to expand the chemical space and leverage sparse and heterogeneous data. This leads to the design of PROTACs, Molecular Glues, and Small Molecule.

ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery & therapeutics.

AI Metrics is an early stage company creating transformational image analysis technology that positions radiologists to be the most efficient, valuable clinicians in the patient care continuum

Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this.

Hermes Biosciences describes a benchtop, hands-off extracellular vesicle isolation system designed to purify exosomes quickly, efficiently.